User login
Before the Parade Passes By, Be Sure to Cross the Street
Are we in Pamplona, Spain, or San Diego, California?
The differences might blur Saturday morning; it won’t be Pamplona’s running of the bulls in front of the San Diego Convention Center, but a cattle drive of long-horned cattle. And this frontier drive may create a few difficulties getting to and from the Vascular Annual Meeting.
The cattle will travel on Harbor Drive, the street directly in front of the San Diego Convention Center, VAM’s home and the VAM headquarters hotel, the Marriot Marquis San Diego Marina.
The route will affect the ability to cross Harbor Drive (from other hotels, for example) and will delay anyone attempting to leave the Marriott via car or taxi while the parade is passing by.
For those staying in San Diego after VAM, the fair opens June 2 and runs through July 4. Fun includes panning for gold, a Wild West saloon with an old-fashioned player piano, and chance encounters with notorious outlaws such as Jesse James and Black Bart.
Are we in Pamplona, Spain, or San Diego, California?
The differences might blur Saturday morning; it won’t be Pamplona’s running of the bulls in front of the San Diego Convention Center, but a cattle drive of long-horned cattle. And this frontier drive may create a few difficulties getting to and from the Vascular Annual Meeting.
The cattle will travel on Harbor Drive, the street directly in front of the San Diego Convention Center, VAM’s home and the VAM headquarters hotel, the Marriot Marquis San Diego Marina.
The route will affect the ability to cross Harbor Drive (from other hotels, for example) and will delay anyone attempting to leave the Marriott via car or taxi while the parade is passing by.
For those staying in San Diego after VAM, the fair opens June 2 and runs through July 4. Fun includes panning for gold, a Wild West saloon with an old-fashioned player piano, and chance encounters with notorious outlaws such as Jesse James and Black Bart.
Are we in Pamplona, Spain, or San Diego, California?
The differences might blur Saturday morning; it won’t be Pamplona’s running of the bulls in front of the San Diego Convention Center, but a cattle drive of long-horned cattle. And this frontier drive may create a few difficulties getting to and from the Vascular Annual Meeting.
The cattle will travel on Harbor Drive, the street directly in front of the San Diego Convention Center, VAM’s home and the VAM headquarters hotel, the Marriot Marquis San Diego Marina.
The route will affect the ability to cross Harbor Drive (from other hotels, for example) and will delay anyone attempting to leave the Marriott via car or taxi while the parade is passing by.
For those staying in San Diego after VAM, the fair opens June 2 and runs through July 4. Fun includes panning for gold, a Wild West saloon with an old-fashioned player piano, and chance encounters with notorious outlaws such as Jesse James and Black Bart.
How to Welcome a Patient Advisor to Your Research Team
When it comes to caring for those with vascular disease, who better to tell surgeons and researchers the effects of various treatments than … patients?
Patients who have completed a comprehensive Patient Advisors Course will provide their perspective Thursday afternoon in “Patient Advisors Program,” 2:30 to 3:30 p.m., with a reception to further the conversation immediately afterward, from 3:30 to 4:30 p.m.
This session has been more than a year in the making, the fruition of a project funded by the Patient-Centered Outcomes Research Institute on “Connecting Patients and Researchers to Engage in Patient-Centered Vascular Disease Research.” Adrienne Faerber, PhD, at the Dartmouth Institute for Health Policy and Clinical Research is leading the project in partnership with SVS member Philip Goodney, MD.
The patients attending VAM have completed an online course aimed at patient collaboration with researchers and clinicians. Researchers, clinicians, and clinical leaders all should find the session valuable, said Dr. Faerber. Major funding agencies are moving toward requiring patients to give their input on research proposals, she said.
“And clinicians who want to improve their care of patients and clinical leaders who want to learn about leading change initiatives will want to listen to what they have to say as well.
“Patients are the experts in living with vascular diseases and we should be listening to them.”
Their experience encompasses far more than just their treatment, Dr. Faerber said of patients, with questions – even if they don’t know to ask them – that involve far more than “stent or surgery.”
“Surgeons tend to think of risks and benefits of procedures. But patients find the post-operative recovery a really important part of the experience,” she said. Surgeons should discuss pain management and any lifestyle restrictions; for example, a patient might not know until after surgery that he cannot drive for six or eight weeks.
“In the patient-centered view, that’s a huge issue,” she said.
“Providing good care goes beyond recommending a treatment,” said Dr. Faerber. “Clinicians need their patients’ input as to what they want, their values and beliefs.” Considering all those factors, plus lifestyle, “may change your thinking on the treatment decision.”
The Thursday session includes an orientation to patient-centered research and patient advisors, conversations with patients about their experiences and how clinics and hospitals can improve the patient experience of those with vascular care plus clinician and researcher reactions.
Dr. Matthew Corriere will discuss parallels between the patients’ stories to his work evaluating what matters to patients undergoing treatment, and Dr. Philip Goodney will describe how patient advisors have helped him improve his research portfolio.
The reception following the session will provide an opportunity to talk with the patient advisors and find out more about adding a Patient Advisor to a research or quality improvement team.
For more information, visit patientadvisorscourse.com.
Thursday, June 1
2:30 – 3:30 p.m.
SDCC, Room 17B
Patient Advisors Program
Moderators: Adrienne Faerber, PhD and Philip Goodney, MD
3:30 – 4:30 p.m.
SDCC, Room 17B
Patient Advisors Program Reception
When it comes to caring for those with vascular disease, who better to tell surgeons and researchers the effects of various treatments than … patients?
Patients who have completed a comprehensive Patient Advisors Course will provide their perspective Thursday afternoon in “Patient Advisors Program,” 2:30 to 3:30 p.m., with a reception to further the conversation immediately afterward, from 3:30 to 4:30 p.m.
This session has been more than a year in the making, the fruition of a project funded by the Patient-Centered Outcomes Research Institute on “Connecting Patients and Researchers to Engage in Patient-Centered Vascular Disease Research.” Adrienne Faerber, PhD, at the Dartmouth Institute for Health Policy and Clinical Research is leading the project in partnership with SVS member Philip Goodney, MD.
The patients attending VAM have completed an online course aimed at patient collaboration with researchers and clinicians. Researchers, clinicians, and clinical leaders all should find the session valuable, said Dr. Faerber. Major funding agencies are moving toward requiring patients to give their input on research proposals, she said.
“And clinicians who want to improve their care of patients and clinical leaders who want to learn about leading change initiatives will want to listen to what they have to say as well.
“Patients are the experts in living with vascular diseases and we should be listening to them.”
Their experience encompasses far more than just their treatment, Dr. Faerber said of patients, with questions – even if they don’t know to ask them – that involve far more than “stent or surgery.”
“Surgeons tend to think of risks and benefits of procedures. But patients find the post-operative recovery a really important part of the experience,” she said. Surgeons should discuss pain management and any lifestyle restrictions; for example, a patient might not know until after surgery that he cannot drive for six or eight weeks.
“In the patient-centered view, that’s a huge issue,” she said.
“Providing good care goes beyond recommending a treatment,” said Dr. Faerber. “Clinicians need their patients’ input as to what they want, their values and beliefs.” Considering all those factors, plus lifestyle, “may change your thinking on the treatment decision.”
The Thursday session includes an orientation to patient-centered research and patient advisors, conversations with patients about their experiences and how clinics and hospitals can improve the patient experience of those with vascular care plus clinician and researcher reactions.
Dr. Matthew Corriere will discuss parallels between the patients’ stories to his work evaluating what matters to patients undergoing treatment, and Dr. Philip Goodney will describe how patient advisors have helped him improve his research portfolio.
The reception following the session will provide an opportunity to talk with the patient advisors and find out more about adding a Patient Advisor to a research or quality improvement team.
For more information, visit patientadvisorscourse.com.
Thursday, June 1
2:30 – 3:30 p.m.
SDCC, Room 17B
Patient Advisors Program
Moderators: Adrienne Faerber, PhD and Philip Goodney, MD
3:30 – 4:30 p.m.
SDCC, Room 17B
Patient Advisors Program Reception
When it comes to caring for those with vascular disease, who better to tell surgeons and researchers the effects of various treatments than … patients?
Patients who have completed a comprehensive Patient Advisors Course will provide their perspective Thursday afternoon in “Patient Advisors Program,” 2:30 to 3:30 p.m., with a reception to further the conversation immediately afterward, from 3:30 to 4:30 p.m.
This session has been more than a year in the making, the fruition of a project funded by the Patient-Centered Outcomes Research Institute on “Connecting Patients and Researchers to Engage in Patient-Centered Vascular Disease Research.” Adrienne Faerber, PhD, at the Dartmouth Institute for Health Policy and Clinical Research is leading the project in partnership with SVS member Philip Goodney, MD.
The patients attending VAM have completed an online course aimed at patient collaboration with researchers and clinicians. Researchers, clinicians, and clinical leaders all should find the session valuable, said Dr. Faerber. Major funding agencies are moving toward requiring patients to give their input on research proposals, she said.
“And clinicians who want to improve their care of patients and clinical leaders who want to learn about leading change initiatives will want to listen to what they have to say as well.
“Patients are the experts in living with vascular diseases and we should be listening to them.”
Their experience encompasses far more than just their treatment, Dr. Faerber said of patients, with questions – even if they don’t know to ask them – that involve far more than “stent or surgery.”
“Surgeons tend to think of risks and benefits of procedures. But patients find the post-operative recovery a really important part of the experience,” she said. Surgeons should discuss pain management and any lifestyle restrictions; for example, a patient might not know until after surgery that he cannot drive for six or eight weeks.
“In the patient-centered view, that’s a huge issue,” she said.
“Providing good care goes beyond recommending a treatment,” said Dr. Faerber. “Clinicians need their patients’ input as to what they want, their values and beliefs.” Considering all those factors, plus lifestyle, “may change your thinking on the treatment decision.”
The Thursday session includes an orientation to patient-centered research and patient advisors, conversations with patients about their experiences and how clinics and hospitals can improve the patient experience of those with vascular care plus clinician and researcher reactions.
Dr. Matthew Corriere will discuss parallels between the patients’ stories to his work evaluating what matters to patients undergoing treatment, and Dr. Philip Goodney will describe how patient advisors have helped him improve his research portfolio.
The reception following the session will provide an opportunity to talk with the patient advisors and find out more about adding a Patient Advisor to a research or quality improvement team.
For more information, visit patientadvisorscourse.com.
Thursday, June 1
2:30 – 3:30 p.m.
SDCC, Room 17B
Patient Advisors Program
Moderators: Adrienne Faerber, PhD and Philip Goodney, MD
3:30 – 4:30 p.m.
SDCC, Room 17B
Patient Advisors Program Reception
See Photos from VRIC
This year we have photographic proof – VRIC is a great experience for researchers. Invigorating discussions, great speakers, inspiration, new ideas – it was all part of the Vascular Research Initiatives Conference in Minneapolis. See our photo album on Flickr or watch the slide show version on YouTube.
This year we have photographic proof – VRIC is a great experience for researchers. Invigorating discussions, great speakers, inspiration, new ideas – it was all part of the Vascular Research Initiatives Conference in Minneapolis. See our photo album on Flickr or watch the slide show version on YouTube.
This year we have photographic proof – VRIC is a great experience for researchers. Invigorating discussions, great speakers, inspiration, new ideas – it was all part of the Vascular Research Initiatives Conference in Minneapolis. See our photo album on Flickr or watch the slide show version on YouTube.
Going to VAM? Don’t Forget the Mobile App
Have VAM at your fingertips with the Mobile App. You can:
- Take your MOC assessment tests via a link within the app
- Access all abstracts, schedules and speaker bios
- Create your own agenda of sessions and events
- Bookmark abstracts of interest
- View maps
- View attendees and private message them
- Share photos and status updates …
- ... and much more
There’s a version for iPhones and one for Android phones.
Have VAM at your fingertips with the Mobile App. You can:
- Take your MOC assessment tests via a link within the app
- Access all abstracts, schedules and speaker bios
- Create your own agenda of sessions and events
- Bookmark abstracts of interest
- View maps
- View attendees and private message them
- Share photos and status updates …
- ... and much more
There’s a version for iPhones and one for Android phones.
Have VAM at your fingertips with the Mobile App. You can:
- Take your MOC assessment tests via a link within the app
- Access all abstracts, schedules and speaker bios
- Create your own agenda of sessions and events
- Bookmark abstracts of interest
- View maps
- View attendees and private message them
- Share photos and status updates …
- ... and much more
There’s a version for iPhones and one for Android phones.
Are you prepared for MACRA?
MACRA (Medicare Access and CHIP Reauthorization Act of 2015) replaces the flawed sustainable growth rate (SGR) formula and significantly changes the way Medicare pays physicians.
Many things about the Affordable Care Act (ACA; Obamacare) are likely to change under the new administration, but MACRA and the commitment to cost-effective, value-based care is here to stay. MACRA is separate from the ACA. Congress overwhelmingly passed MACRA legislation with bipartisan support. MACRA will eventually transition physicians toward more value-based payments.
It is important to understand MACRA to ensure you are doing everything required under the current rules in 2017. Ignore MACRA in 2017 and you will face an automatic reduction of 4% to your payments under Medicare in 2019.
AGA offers educational webinars and videos to help you prepare. Visit gastro.org/MACRA to learn more.
MACRA (Medicare Access and CHIP Reauthorization Act of 2015) replaces the flawed sustainable growth rate (SGR) formula and significantly changes the way Medicare pays physicians.
Many things about the Affordable Care Act (ACA; Obamacare) are likely to change under the new administration, but MACRA and the commitment to cost-effective, value-based care is here to stay. MACRA is separate from the ACA. Congress overwhelmingly passed MACRA legislation with bipartisan support. MACRA will eventually transition physicians toward more value-based payments.
It is important to understand MACRA to ensure you are doing everything required under the current rules in 2017. Ignore MACRA in 2017 and you will face an automatic reduction of 4% to your payments under Medicare in 2019.
AGA offers educational webinars and videos to help you prepare. Visit gastro.org/MACRA to learn more.
MACRA (Medicare Access and CHIP Reauthorization Act of 2015) replaces the flawed sustainable growth rate (SGR) formula and significantly changes the way Medicare pays physicians.
Many things about the Affordable Care Act (ACA; Obamacare) are likely to change under the new administration, but MACRA and the commitment to cost-effective, value-based care is here to stay. MACRA is separate from the ACA. Congress overwhelmingly passed MACRA legislation with bipartisan support. MACRA will eventually transition physicians toward more value-based payments.
It is important to understand MACRA to ensure you are doing everything required under the current rules in 2017. Ignore MACRA in 2017 and you will face an automatic reduction of 4% to your payments under Medicare in 2019.
AGA offers educational webinars and videos to help you prepare. Visit gastro.org/MACRA to learn more.
2018 AGA Fellows Program now accepting applications
The application period for the 2018 AGA Fellows Program is now open. The program recognizes members whose accomplishments demonstrate personal commitment to the field of gastroenterology with the distinction of fellowship.
AGA Fellows receive this honor from AGA for their superior professional achievement in clinical private or academic practice and in basic or clinical research.
AGA Fellows receive:
- The privilege of using the designation “AGAF” in professional activities.
- An official certificate and pin denoting your status.
- A listing on the AGA website.
And more.
Apply today to join this international community of excellence.
Find more information, including the list of benefits and criteria for fellowship, at www.gastro.org/fellowship. The deadline for application submissions is Monday, July 31, 2017.
The application period for the 2018 AGA Fellows Program is now open. The program recognizes members whose accomplishments demonstrate personal commitment to the field of gastroenterology with the distinction of fellowship.
AGA Fellows receive this honor from AGA for their superior professional achievement in clinical private or academic practice and in basic or clinical research.
AGA Fellows receive:
- The privilege of using the designation “AGAF” in professional activities.
- An official certificate and pin denoting your status.
- A listing on the AGA website.
And more.
Apply today to join this international community of excellence.
Find more information, including the list of benefits and criteria for fellowship, at www.gastro.org/fellowship. The deadline for application submissions is Monday, July 31, 2017.
The application period for the 2018 AGA Fellows Program is now open. The program recognizes members whose accomplishments demonstrate personal commitment to the field of gastroenterology with the distinction of fellowship.
AGA Fellows receive this honor from AGA for their superior professional achievement in clinical private or academic practice and in basic or clinical research.
AGA Fellows receive:
- The privilege of using the designation “AGAF” in professional activities.
- An official certificate and pin denoting your status.
- A listing on the AGA website.
And more.
Apply today to join this international community of excellence.
Find more information, including the list of benefits and criteria for fellowship, at www.gastro.org/fellowship. The deadline for application submissions is Monday, July 31, 2017.
AGA recognizes 52 investigators with research funding
The AGA Research Foundation is thrilled to award 52 researchers with research funding in the 2017 award year.
“The AGA Research Foundation has a proven track record of funding young investigators who subsequently achieve great success in research. We are confident that the 2017 class will be no exception,” said Robert S. Sandler, MD, MPH, AGAF, chair, AGA Research Foundation. “AGA is honored to invest in this year’s award recipients and looks forward to seeing how each research project contributes to advancing the field of gastroenterology.”
The AGA Research Award Program serves to support talented investigators who are pursuing careers in digestive disease research. A grant from the AGA Research Foundation ensures that a major proportion of the recipient’s time is protected for research.
The awards program is made possible thanks to generous donors and funders contributing to the AGA Research Foundation. Show your support for GI research.
To learn about upcoming research funding opportunities, and to view the list of this years’ winners, visit www.gastro.org/awards.
This year’s honorees were recognized during several AGA Research Foundation events at Digestive Disease Week® 2017, which took place May 6-9 in Chicago, IL.
The AGA Research Foundation is thrilled to award 52 researchers with research funding in the 2017 award year.
“The AGA Research Foundation has a proven track record of funding young investigators who subsequently achieve great success in research. We are confident that the 2017 class will be no exception,” said Robert S. Sandler, MD, MPH, AGAF, chair, AGA Research Foundation. “AGA is honored to invest in this year’s award recipients and looks forward to seeing how each research project contributes to advancing the field of gastroenterology.”
The AGA Research Award Program serves to support talented investigators who are pursuing careers in digestive disease research. A grant from the AGA Research Foundation ensures that a major proportion of the recipient’s time is protected for research.
The awards program is made possible thanks to generous donors and funders contributing to the AGA Research Foundation. Show your support for GI research.
To learn about upcoming research funding opportunities, and to view the list of this years’ winners, visit www.gastro.org/awards.
This year’s honorees were recognized during several AGA Research Foundation events at Digestive Disease Week® 2017, which took place May 6-9 in Chicago, IL.
The AGA Research Foundation is thrilled to award 52 researchers with research funding in the 2017 award year.
“The AGA Research Foundation has a proven track record of funding young investigators who subsequently achieve great success in research. We are confident that the 2017 class will be no exception,” said Robert S. Sandler, MD, MPH, AGAF, chair, AGA Research Foundation. “AGA is honored to invest in this year’s award recipients and looks forward to seeing how each research project contributes to advancing the field of gastroenterology.”
The AGA Research Award Program serves to support talented investigators who are pursuing careers in digestive disease research. A grant from the AGA Research Foundation ensures that a major proportion of the recipient’s time is protected for research.
The awards program is made possible thanks to generous donors and funders contributing to the AGA Research Foundation. Show your support for GI research.
To learn about upcoming research funding opportunities, and to view the list of this years’ winners, visit www.gastro.org/awards.
This year’s honorees were recognized during several AGA Research Foundation events at Digestive Disease Week® 2017, which took place May 6-9 in Chicago, IL.
Contribute to Clowes Lecture Fund
The recent annual Vascular Research Initiatives Conference featured the inaugural Alexander W. Clowes Distinguished Lecture. The invited presentation – planned to be a yearly event – honors the late Alexander Clowes, a vascular surgeon, scientist and SVS Lifetime Achievement Award-winner, and seeks to continue his considerable legacy.
The SVS Foundation has established a fund for donations to support the Clowes Distinguished Lecture in perpetuity. Learn more about the lecture, Dr. Clowes and how to contribute here.
The recent annual Vascular Research Initiatives Conference featured the inaugural Alexander W. Clowes Distinguished Lecture. The invited presentation – planned to be a yearly event – honors the late Alexander Clowes, a vascular surgeon, scientist and SVS Lifetime Achievement Award-winner, and seeks to continue his considerable legacy.
The SVS Foundation has established a fund for donations to support the Clowes Distinguished Lecture in perpetuity. Learn more about the lecture, Dr. Clowes and how to contribute here.
The recent annual Vascular Research Initiatives Conference featured the inaugural Alexander W. Clowes Distinguished Lecture. The invited presentation – planned to be a yearly event – honors the late Alexander Clowes, a vascular surgeon, scientist and SVS Lifetime Achievement Award-winner, and seeks to continue his considerable legacy.
The SVS Foundation has established a fund for donations to support the Clowes Distinguished Lecture in perpetuity. Learn more about the lecture, Dr. Clowes and how to contribute here.
VAM 2017 Features Alliances and Teamwork
This year’s Vascular Annual Meeting could be subtitled: “The Year of Inter-Society Collaboration.”
Last year, joint sessions with specialty societies that have overlapping interests proved so popular that the number of such sessions was expanded for 2017.
“These sessions provide a multidisciplinary perspective on our common problems, and showcase the SVS’ leadership role in vascular disease diagnosis and management,” said Dr. Ron Dalman, chair of the SVS VAM Program Committee.
“While our specialty encompasses broad expertise across the spectrum of vascular disease, as SVS members we also are interested in what we can learn from others. We want to advance the field, share information and hear how other perspectives may contribute to improved patient care.”
Dr. Kellie Brown, chair of the SVS Postgraduate Education Committee, agreed. “Collaboration helps us have a broader impact on disease management,” she said.
Seven societies are working with SVS members on eight joint programs, nearly double the number in 2016. They are: American Podiatric Medical Association, American Venous Forum, European Society for Vascular Surgery, Society of Thoracic Surgeons, Society for Vascular Medicine, Society for Vascular Nursing and the Society for Vascular Ultrasound.
Here are the 2017 joint sessions:
Wednesday, May 31Postgraduate course2 – 5 p.m.The APMA returns with another joint postgraduate course, “Advances in Wound Care and Limb Management.”
Friday, June 2Concurrent Sessions3:30 – 5 p.m.C5: SVS/ESVS: “Joint Debate Session”C6: SVS/STS: “Sharing Common Ground for Cardiovascular Problems”C7: SVS/AVF: “How and When to Treat Deep Venous Obstructions”
Saturday, June 3Concurrent Sessions10:30 a.m. – 12 p.m.C12: SVS/SVM: “Medical Management of Vascular Disease”C13: SVS/SVN: “Building the Vascular Team – Evolving Collaboration of Surgeons and Nurses”C14: SVS/SVU: “Organization, Operation and Management of a Vascular Laboratory”1:30 – 5:15 p.m. SVS/STS Summit: “Advances and Controversies in the Management of Complex Thoracoabdominal Aneurysmal Disease and Type B Aortic Dissection.” STS is co-sponsoring the session. Moderators for the thoracoabdominal portion are Dr. Jason T. Lee (SVS) and Dr. Wilson Szeto (STS); moderators for the portion on Type B aortic dissection are Dr. Matthew Eagleton (SVS) and Dr. Michael Fischbein (STS).
This year’s Vascular Annual Meeting could be subtitled: “The Year of Inter-Society Collaboration.”
Last year, joint sessions with specialty societies that have overlapping interests proved so popular that the number of such sessions was expanded for 2017.
“These sessions provide a multidisciplinary perspective on our common problems, and showcase the SVS’ leadership role in vascular disease diagnosis and management,” said Dr. Ron Dalman, chair of the SVS VAM Program Committee.
“While our specialty encompasses broad expertise across the spectrum of vascular disease, as SVS members we also are interested in what we can learn from others. We want to advance the field, share information and hear how other perspectives may contribute to improved patient care.”
Dr. Kellie Brown, chair of the SVS Postgraduate Education Committee, agreed. “Collaboration helps us have a broader impact on disease management,” she said.
Seven societies are working with SVS members on eight joint programs, nearly double the number in 2016. They are: American Podiatric Medical Association, American Venous Forum, European Society for Vascular Surgery, Society of Thoracic Surgeons, Society for Vascular Medicine, Society for Vascular Nursing and the Society for Vascular Ultrasound.
Here are the 2017 joint sessions:
Wednesday, May 31Postgraduate course2 – 5 p.m.The APMA returns with another joint postgraduate course, “Advances in Wound Care and Limb Management.”
Friday, June 2Concurrent Sessions3:30 – 5 p.m.C5: SVS/ESVS: “Joint Debate Session”C6: SVS/STS: “Sharing Common Ground for Cardiovascular Problems”C7: SVS/AVF: “How and When to Treat Deep Venous Obstructions”
Saturday, June 3Concurrent Sessions10:30 a.m. – 12 p.m.C12: SVS/SVM: “Medical Management of Vascular Disease”C13: SVS/SVN: “Building the Vascular Team – Evolving Collaboration of Surgeons and Nurses”C14: SVS/SVU: “Organization, Operation and Management of a Vascular Laboratory”1:30 – 5:15 p.m. SVS/STS Summit: “Advances and Controversies in the Management of Complex Thoracoabdominal Aneurysmal Disease and Type B Aortic Dissection.” STS is co-sponsoring the session. Moderators for the thoracoabdominal portion are Dr. Jason T. Lee (SVS) and Dr. Wilson Szeto (STS); moderators for the portion on Type B aortic dissection are Dr. Matthew Eagleton (SVS) and Dr. Michael Fischbein (STS).
This year’s Vascular Annual Meeting could be subtitled: “The Year of Inter-Society Collaboration.”
Last year, joint sessions with specialty societies that have overlapping interests proved so popular that the number of such sessions was expanded for 2017.
“These sessions provide a multidisciplinary perspective on our common problems, and showcase the SVS’ leadership role in vascular disease diagnosis and management,” said Dr. Ron Dalman, chair of the SVS VAM Program Committee.
“While our specialty encompasses broad expertise across the spectrum of vascular disease, as SVS members we also are interested in what we can learn from others. We want to advance the field, share information and hear how other perspectives may contribute to improved patient care.”
Dr. Kellie Brown, chair of the SVS Postgraduate Education Committee, agreed. “Collaboration helps us have a broader impact on disease management,” she said.
Seven societies are working with SVS members on eight joint programs, nearly double the number in 2016. They are: American Podiatric Medical Association, American Venous Forum, European Society for Vascular Surgery, Society of Thoracic Surgeons, Society for Vascular Medicine, Society for Vascular Nursing and the Society for Vascular Ultrasound.
Here are the 2017 joint sessions:
Wednesday, May 31Postgraduate course2 – 5 p.m.The APMA returns with another joint postgraduate course, “Advances in Wound Care and Limb Management.”
Friday, June 2Concurrent Sessions3:30 – 5 p.m.C5: SVS/ESVS: “Joint Debate Session”C6: SVS/STS: “Sharing Common Ground for Cardiovascular Problems”C7: SVS/AVF: “How and When to Treat Deep Venous Obstructions”
Saturday, June 3Concurrent Sessions10:30 a.m. – 12 p.m.C12: SVS/SVM: “Medical Management of Vascular Disease”C13: SVS/SVN: “Building the Vascular Team – Evolving Collaboration of Surgeons and Nurses”C14: SVS/SVU: “Organization, Operation and Management of a Vascular Laboratory”1:30 – 5:15 p.m. SVS/STS Summit: “Advances and Controversies in the Management of Complex Thoracoabdominal Aneurysmal Disease and Type B Aortic Dissection.” STS is co-sponsoring the session. Moderators for the thoracoabdominal portion are Dr. Jason T. Lee (SVS) and Dr. Wilson Szeto (STS); moderators for the portion on Type B aortic dissection are Dr. Matthew Eagleton (SVS) and Dr. Michael Fischbein (STS).
Learn Ins and Outs of Launching a Multicenter Clinical Trial
To help SVS members learn the necessary steps of setting up a multicenter clinical research study, this year’s Vascular Annual Meeting offers “The Nuts and Bolts of a Multicenter Clinical Trial.” The concurrent session will be held from 5 to 6:30 p.m. Wednesday, VAM’s opening day.
“The most accepted method of definitively answering questions is a clinical trial,” said SVS Clinical Research Committee Chair and co-moderator, Dr. Raul Guzman. Though many SVS members have participated in multicenter trials, “They’re not easy endeavors,” said Dr. Guzman. “It takes time, commitment and money to really push forward an idea for a multicenter trial from the ground up.”
“Nuts and Bolts” will provide an insider’s view of effective approaches and processes for launching a multicenter clinical trial, focusing on the best strategies and the challenges involved. “We hope that at the end of the session, attendees will have sufficient detail about this process so they could begin their own trial. We want to provide an initial education,” Dr. Guzman said.
Speakers include SVS members who are successful clinical investigators:
Dr. Brajesh Lal, will speak on “How to Get Started – Perspectives from CREST and CREST-2”
Dr. Alik Farber, “Trial Execution – Tips from the BEST-CLI Trial Investigators”
Dr. B. Timothy Baxter, “The End Game, Finishing Your Trial – How We Did It in NTA^3CT”
Dr. C. Keith Ozaki, “The Small Multicenter Randomized Trial – Involving Your Friends and Neighbors”
Dr. Philip Goodney, “Patient-Oriented Research – A Multicenter Approach to PCORI Trials”
“A discussion about how to overcome challenges and avoid potential pitfalls that can be encountered during the various stages of trial execution are an important part of the course. “Our speakers will discuss not only what they did well, but what they could do better,” said Dr. Guzman.
Many members have questions that need answers, he said. “I would venture to say that most SVS members have had an idea for a clinical trial. They’ve formed the basis of a trial but there are so many challenges that they’ve been discouraged. One of the questions is, “Where do you even start?’
“We think we’ll be able to answer that for them,” Dr. Guzman said.
Wednesday, May 31
5 – 6:30 p.m.
C2: The Nuts and Bolts of a Multicenter Clinical Trial
To help SVS members learn the necessary steps of setting up a multicenter clinical research study, this year’s Vascular Annual Meeting offers “The Nuts and Bolts of a Multicenter Clinical Trial.” The concurrent session will be held from 5 to 6:30 p.m. Wednesday, VAM’s opening day.
“The most accepted method of definitively answering questions is a clinical trial,” said SVS Clinical Research Committee Chair and co-moderator, Dr. Raul Guzman. Though many SVS members have participated in multicenter trials, “They’re not easy endeavors,” said Dr. Guzman. “It takes time, commitment and money to really push forward an idea for a multicenter trial from the ground up.”
“Nuts and Bolts” will provide an insider’s view of effective approaches and processes for launching a multicenter clinical trial, focusing on the best strategies and the challenges involved. “We hope that at the end of the session, attendees will have sufficient detail about this process so they could begin their own trial. We want to provide an initial education,” Dr. Guzman said.
Speakers include SVS members who are successful clinical investigators:
Dr. Brajesh Lal, will speak on “How to Get Started – Perspectives from CREST and CREST-2”
Dr. Alik Farber, “Trial Execution – Tips from the BEST-CLI Trial Investigators”
Dr. B. Timothy Baxter, “The End Game, Finishing Your Trial – How We Did It in NTA^3CT”
Dr. C. Keith Ozaki, “The Small Multicenter Randomized Trial – Involving Your Friends and Neighbors”
Dr. Philip Goodney, “Patient-Oriented Research – A Multicenter Approach to PCORI Trials”
“A discussion about how to overcome challenges and avoid potential pitfalls that can be encountered during the various stages of trial execution are an important part of the course. “Our speakers will discuss not only what they did well, but what they could do better,” said Dr. Guzman.
Many members have questions that need answers, he said. “I would venture to say that most SVS members have had an idea for a clinical trial. They’ve formed the basis of a trial but there are so many challenges that they’ve been discouraged. One of the questions is, “Where do you even start?’
“We think we’ll be able to answer that for them,” Dr. Guzman said.
Wednesday, May 31
5 – 6:30 p.m.
C2: The Nuts and Bolts of a Multicenter Clinical Trial
To help SVS members learn the necessary steps of setting up a multicenter clinical research study, this year’s Vascular Annual Meeting offers “The Nuts and Bolts of a Multicenter Clinical Trial.” The concurrent session will be held from 5 to 6:30 p.m. Wednesday, VAM’s opening day.
“The most accepted method of definitively answering questions is a clinical trial,” said SVS Clinical Research Committee Chair and co-moderator, Dr. Raul Guzman. Though many SVS members have participated in multicenter trials, “They’re not easy endeavors,” said Dr. Guzman. “It takes time, commitment and money to really push forward an idea for a multicenter trial from the ground up.”
“Nuts and Bolts” will provide an insider’s view of effective approaches and processes for launching a multicenter clinical trial, focusing on the best strategies and the challenges involved. “We hope that at the end of the session, attendees will have sufficient detail about this process so they could begin their own trial. We want to provide an initial education,” Dr. Guzman said.
Speakers include SVS members who are successful clinical investigators:
Dr. Brajesh Lal, will speak on “How to Get Started – Perspectives from CREST and CREST-2”
Dr. Alik Farber, “Trial Execution – Tips from the BEST-CLI Trial Investigators”
Dr. B. Timothy Baxter, “The End Game, Finishing Your Trial – How We Did It in NTA^3CT”
Dr. C. Keith Ozaki, “The Small Multicenter Randomized Trial – Involving Your Friends and Neighbors”
Dr. Philip Goodney, “Patient-Oriented Research – A Multicenter Approach to PCORI Trials”
“A discussion about how to overcome challenges and avoid potential pitfalls that can be encountered during the various stages of trial execution are an important part of the course. “Our speakers will discuss not only what they did well, but what they could do better,” said Dr. Guzman.
Many members have questions that need answers, he said. “I would venture to say that most SVS members have had an idea for a clinical trial. They’ve formed the basis of a trial but there are so many challenges that they’ve been discouraged. One of the questions is, “Where do you even start?’
“We think we’ll be able to answer that for them,” Dr. Guzman said.
Wednesday, May 31
5 – 6:30 p.m.
C2: The Nuts and Bolts of a Multicenter Clinical Trial